| P50 | author | Bevan Yueh | Q42208740 |
| P2093 | author name string | Ashok Saluja | |
| | Veena Sangwan | |
| | Rui Lin | |
| | Caitlin Fujisawa | |
| | Emiro Caicedo-Granados | |
| P2860 | cites work | Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States | Q22306233 |
| | In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 |
| | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| | Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 |
| | Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. | Q33209208 |
| | Human papillomavirus immortalization and transformation functions | Q33962694 |
| | Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors | Q34379259 |
| | Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis | Q34565515 |
| | Small molecule inhibitors of human papillomavirus protein - protein interactions | Q35107717 |
| | Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. | Q36710840 |
| | Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) | Q36717554 |
| | A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer | Q36851289 |
| | Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins | Q37419555 |
| | Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma | Q37549460 |
| | Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest | Q39191981 |
| | Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo | Q39821586 |
| | E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells | Q39874615 |
| | Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. | Q40073570 |
| | Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells | Q40410781 |
| | Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. | Q40447456 |
| | Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters | Q42820344 |
| | Prevalence of oral HPV infection in the United States, 2009-2010. | Q43794722 |
| | China approves first gene therapy | Q44580430 |
| | Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo | Q46054917 |
| | Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii | Q50135757 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1149-1156 | |
| P577 | publication date | 2014-10-11 | |
| P1433 | published in | Oral Oncology | Q7099367 |
| P1476 | title | Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma | |
| P478 | volume | 50 | |